|
⚲
|
| Keyboard |
| Polaris Management Co VII LLC
✚
|
|
|---|---|
| CIK # | 0001678203 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001678203] | |
| 4 | [0001678203] | |
| SC 13D | [0001678203] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Polaris Management Co VII LLC | Camp4 Therapeutics Corp | [2024-10-22] |
| Polaris Management Co VII LLC | SQZ Biotechnologies Co | [2020-11-13] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Camp4 Therapeutics Corp CAMP
Common Stock
|
2024-10-15 | Conversion | 87,448 | ||
|
Camp4 Therapeutics Corp CAMP
Common Stock
|
2024-10-15 | Conversion | 1,250,061 | ||
|
Camp4 Therapeutics Corp CAMP
Common Stock
|
2024-10-15 | Conversion | 24,745 | ||
|
Camp4 Therapeutics Corp CAMP
Common Stock
|
2024-10-15 | Buy | 909,090 | $11.00 | 9,999,990 |
|
Camp4 Therapeutics Corp CAMP
Common Stock
|
2024-10-15 | Conversion | 353,718 | ||
|
Camp4 Therapeutics Corp CAMP
Series B Preferred Stock · derivative
|
2024-10-15 | Conversion | 277,536 | ||
|
Camp4 Therapeutics Corp CAMP
Series B Preferred Stock · derivative
|
2024-10-15 | Conversion | 3,967,234 | ||
|
Camp4 Therapeutics Corp CAMP
Series A Prime Preferred Stock · derivative
|
2024-10-15 | Conversion | 14,020,475 | ||
|
Camp4 Therapeutics Corp CAMP
Series A Prime Preferred Stock · derivative
|
2024-10-15 | Conversion | 980,829 | ||
|
SQZ Biotechnologies Co SQZ
Series B Convertible Preferred Stock · derivative
|
2020-11-03 | Conversion | 56,462 | ||
|
SQZ Biotechnologies Co SQZ
Common Stock
|
2020-11-03 | Buy | 16,346 | $16.00 | 261,536 |
|
SQZ Biotechnologies Co SQZ
Series A Convertible Preferred Stock · derivative
|
2020-11-03 | Conversion | 28,863 | ||
|
SQZ Biotechnologies Co SQZ
Series A Convertible Preferred Stock · derivative
|
2020-11-03 | Conversion | 412,608 | ||
|
SQZ Biotechnologies Co SQZ
Common Stock
|
2020-11-03 | Buy | 233,654 | $16.00 | 3,738,464 |
|
SQZ Biotechnologies Co SQZ
Common Stock
|
2020-11-03 | Conversion | 2,315,652 | ||
|
SQZ Biotechnologies Co SQZ
Common Stock
|
2020-11-03 | Conversion | 161,994 | ||
|
SQZ Biotechnologies Co SQZ
Series D Convertible Preferred Stock · derivative
|
2020-11-03 | Conversion | 24,397 | ||
|
SQZ Biotechnologies Co SQZ
Series D Convertible Preferred Stock · derivative
|
2020-11-03 | Conversion | 348,725 | ||
|
SQZ Biotechnologies Co SQZ
Series C Convertible Preferred Stock · derivative
|
2020-11-03 | Conversion | 630,672 | ||
|
SQZ Biotechnologies Co SQZ
Series C Convertible Preferred Stock · derivative
|
2020-11-03 | Conversion | 44,120 | ||
| showing 20 of 41 most recent transactions | |||||